Stem Cells in Epithelial Renewal and Cancer of the Intestine

European Gastroenterology and Hepatology Review

Volumn 7, Issue 3, 2011, Pages 154-159

  Ng, Annie ^a   Barker, Nick ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

Author keywords

Cancer; Epithelium; Intestine; Lgr5; Stem cell; Wnt

Indexed keywords

BIOLOGICAL MARKER; BMI1 PROTEIN; CD133 ANTIGEN; CELL MARKER; HERMES ANTIGEN; WNT PROTEIN;

ARTICLE; CANCER STEM CELL; CANCER THERAPY; CARCINOGENESIS; CELL ACTIVITY; CELL DIFFERENTIATION; CELL EXPANSION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; COLORECTAL CANCER; HUMAN; INTESTINE CANCER; MOLECULARLY TARGETED THERAPY; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 84865069589     PISSN: 17583799     EISSN: 17583802     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Marshman E, Booth C, Potten CS, The intestinal epithelial stem cell, Bioessays, 2002;24:91-8.
2. Heath JP, Epithelial cell migration in the intestine, Cell Biol Int, 1996;20:139-46.
3. van der Flier LG, Clevers H, Stem cells, self-renewal, and differentiation in the intestinal epithelium, Annu Rev Physiol, 2009;71:241-60.
4. Reya T, Morrison SJ, Clarke MF, et al., Stem cells, cancer, and cancer stem cells, Nature, 2001;414:105-11.
5. Bjerknes M, Cheng H, Multipotential stem cells in adult mouse gastric epithelium, Am J Physiol Gastrointest Liver Physiol, 2002;283:G767-77.
6. Winton DJ, Gooderham NJ, Boobis AR, et al., Mutagenesis of mouse intestine in vivo using the Dlb-1 specific locus test: studies with 1,2-dimethylhydrazine, dimethylnitrosamine, and the dietary mutagen 2-amino-3,8-dimethylimidazo [4,5-f]quinoxaline, Cancer Res, 1990;50:7992-6.
7. Barker N, Clevers H, Lineage tracing in the intestinal epithelium, Curr Protoc Stem Cell Biol, 2010;Chapter 5:Unit5A.4.
8. Barker N, van Es JH, Jaks V, et al., Very Long-term Self-renewal of Small Intestine, Colon, and Hair Follicles from Cycling Lgr5+ve Stem Cells, Cold Spring Harb Symp Quant Biol, 2008;73:351-6.
9. Barker N, Clevers H, Leucine-rich repeat-containing G-protein-coupled receptors as markers of adult stem cells, Gastroenterology, 2010;138:1681-96.
10. Barker N, van Es JH, Kuipers J, et al., Identification of stem cells in small intestine and colon by marker gene Lgr5, Nature, 2007;449:1003-7.
11. Sato T, Vries RG, Snippert HJ, et al., Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche, Nature, 2009;459:262-5.
12. Sato T, van Es JH, Snippert HJ, et al., Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts, Nature, 2011;469:415-8.
13. Barker N, Bartfeld S, Clevers H, Tissue-resident adult stem cell populations of rapidly self-renewing organs, Cell Stem Cell, 2010;7:656-70.
14. Barker N, van de Wetering M, Clevers H, The intestinal stem cell, Genes Dev, 2008;22:1856-64.
15. Potten CS, Gandara R, Mahida YR, et al., The stem cells of small intestinal crypts: where are they?, Cell Prolif, 2009;42:731-50.
16. Potten CS, Extreme sensitivity of some intestinal crypt cells to X and gamma irradiation, Nature, 1977;269:518-21.
17. Sangiorgi E, Capecchi MR, Bmi1 is expressed in vivo in intestinal stem cells, Nat Genet, 2008;40:915-20.
18. Montgomery RK, Carlone DL, Richmond CA, et al., Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells, Proc Natl Acad Sci U S A, 2011;108:179-84.
19. Demidov ON, Timofeev O, Lwin HN, et al., Wip1 phosphatase regulates p53-dependent apoptosis of stem cells and tumorigenesis in the mouse intestine, Cell Stem Cell, 2007;1:180-90.
20. Gregorieff A, Pinto D, Begthel H, et al., Expression pattern of Wnt signaling components in the adult intestine, Gastroenterology, 2005;129:626-38.
21. He XC, Yin T, Grindley JC, et al., PTEN-deficient intestinal stem cells initiate intestinal polyposis, Nat Genet, 2007;39:189-98.
22. May R, Sureban SM, Hoang N, et al., Doublecortin and CaM kinase-like-1 and leucine-rich-repeat-containing G-protein-coupled receptor mark quiescent and cycling intestinal stem cells, respectively, Stem Cells, 2009;27:2571-9.
23. Cheng H, Leblond CP, Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types, Am J Anat, 1974;141:537-61.
24. Cheng H, Leblond CP, Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. I. Columnar cell, Am J Anat, 1974;141:461-79.
25. Bjerknes M, Cheng H, The stem-cell zone of the small intestinal epithelium. III. Evidence from columnar, enteroendocrine, and mucous cells in the adult mouse, Am J Anat, 1981;160:77-91.
26. Snippert HJ, van der Flier LG, Sato T, et al., Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells, Cell, 2010;143:134-44.
27. van der Flier LG, van Gijn ME, Hatzis P, et al., Transcription factor achaete scute-like 2 controls intestinal stem cell fate, Cell, 2009;136:903-12.
28. Schepers A, Vries R, van den Born M, et al., Lgr5 adult intestinal stem cell characteristics, EMBO J, 2011; in press.
29. Fearon ER, Vogelstein B, A genetic model for colorectal tumorigenesis, Cell, 1990;61:759-67.
30. van den Brink GR, Offerhaus GJ, The morphogenetic code and colon cancer development, Cancer Cell, 2007;11:109-17.
31. Pinto D, Clevers H, Wnt, stem cells and cancer in the intestine, Biol Cell, 2005;97:185-96.
32. Clevers H, Wnt/beta-catenin signaling in development and disease, Cell, 2006;127:469-80.
33. Korinek V, Barker N, Morin PJ, et al., Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma, Science, 1997;275:1784-7.
34. Morin PJ, Sparks AB, Korinek V, et al., Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC, Science, 1997;275:1787-90.
35. van de Wetering M, Sancho E, Verweij C, et al., The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells, Cell, 2002;111:241-50.
36. Van der Flier LG, Sabates-Bellver J, Oving I, et al., The Intestinal Wnt/TCF Signature, Gastroenterology, 2007;132:628-32.
37. Vogelstein B, Fearon ER, Hamilton SR, et al., Genetic alterations during colorectal-tumor development, N Engl J Med, 1988;319:525-32.
38. Maskens AP, Histogenesis of adenomatous polyps in the human large intestine, Gastroenterology, 1979;77:1245-51.
39. Lightdale C, Lipkin M, Deschner E, In vivo measurements in familial polyposis: kinetics and location of proliferating cells in colonic adenomas, Cancer Res, 1982;42:4280-3.
40. Shih IM, Wang TL, Traverso G, et al., Top-down morphogenesis of colorectal tumors, Proc Natl Acad Sci U S A, 2001;98:2640-5.
41. Lamprecht SA, Lipkin M, Migrating colonic crypt epithelial cells: primary targets for transformation, Carcinogenesis, 2002;23:1777-80.
42. Barker N, Ridgway RA, van Es JH, et al., Crypt stem cells as the cells-of-origin of intestinal cancer, Nature, 2009;457:608-11.
43. Zhu L, Gibson P, Currle DS, et al., Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation, Nature, 2009;457:603-7.
44. Barker N, Huch M, Kujala P, et al., Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro, Cell Stem Cell, 2010;6:25-36.
45. Woda BA, Forde K, Lane N, A unicryptal colonic adenoma, the smallest colonic neoplasm yet observed in a non-polyposis individual, Am J Clin Pathol, 1977;68:631-2.
46. Nakamura S, Kino I, Morphogenesis of minute adenomas in familial polyposis coli, J Natl Cancer Inst, 1984;73:41-9.
47. Preston SL, Wong WM, Chan AO, et al., Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission, Cancer Res, 2003;63:3819-25.
48. Lapidot T, Sirard C, Vormoor J, et al., A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, Nature, 1994;367:645-8.
49. O'Brien CA, Pollett A, Gallinger S, et al., A human colon cancer cell capable of initiating tumour growth in immunodeficient mice, Nature, 2007;445:106-10.
50. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al., Identification and expansion of human colon-cancer-initiating cells, Nature, 2007;445:111-5.
51. Dalerba P, Dylla SJ, Park IK, et al., Phenotypic characterization of human colorectal cancer stem cells, Proc Natl Acad Sci U S A, 2007;104:10158-63.
52. Wicha MS, Liu S, Dontu G, Cancer stem cells: an old idea-a paradigm shift, Cancer Res, 2006;66:1883-90; discussion 1895-6.
53. Visvader JE, Lindeman GJ, Cancer stem cells in solid tumours: accumulating evidence and unresolved questions, Nat Rev Cancer, 2008;8:755-68.
54. Vries RG, Huch M, Clevers H, Stem cells and cancer of the stomach and intestine, Mol Oncol, 2010;4:373-84.
55. Todaro M, Alea MP, Di Stefano AB, et al., Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4, Cell Stem Cell, 2007;1:389-402.
56. Dean M, Fojo T, Bates S, Tumour stem cells and drug resistance, Nat Rev Cancer, 2005;5:275-84.
57. Dylla SJ, Beviglia L, Park IK, et al., Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy, PLoS One, 2008;3:e2428.
58. Vermeulen L, Todaro M, de Sousa Mello F, et al., Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity, Proc Natl Acad Sci U S A, 2008;105:13427-32.
59. Du L, Wang H, He L, et al., CD44 is of functional importance for colorectal cancer stem cells, Clin Cancer Res, 2008;14:6751-60.
60. Choi D, Lee HW, Hur KY, et al., Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma, World J Gastroenterol, 2009;15:2258-64.
61. Shmelkov SV, Butler JM, Hooper AT, et al., CD133 expression is not restricted to stem cells, and both CD133+ and CD133-metastatic colon cancer cells initiate tumors, J Clin Invest, 2008;118:2111-20.
62. Lewis A, Segditsas S, Deheragoda M, et al., Severe polyposis in Apc(1322T) mice is associated with submaximal Wnt signalling and increased expression of the stem cell marker Lgr5, Gut, 2010;59:1680-6.
63. Uchida H, Yamazaki K, Fukuma M, et al., Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer, Cancer Sci, 2010;101:1731-7.
64. Becker L, Huang Q, Mashimo H, Immunostaining of Lgr5, an intestinal stem cell marker, in normal and premalignant human gastrointestinal tissue, ScientificWorldJournal, 2008;8:1168-76.
65. Takahashi H, Ishii H, Nishida N, et al., Significance of Lgr5(+ve) Cancer Stem Cells in the Colon and Rectum, Ann Surg Oncol, 2011;18:1166-74.
66. Vermeulen L, De Sousa EMF, van der Heijden M, et al., Wnt activity defines colon cancer stem cells and is regulated by the microenvironment, Nat Cell Biol, 2010;12:468-76.
67. Quintana E, Shackleton M, Sabel MS, et al., Efficient tumour formation by single human melanoma cells, Nature, 2008;456:593-8.
68. De Sousa EMF, Vermeulen L, Richel DJ, Medema JP, Targeting Wnt Signaling in Colon Cancer Stem Cells, Clin Cancer Res, 2011;17:647-53.
69. Snippert HJ, van Es JH, van den Born M, et al., Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine, Gastroenterology, 2009;136:2187-94.e1.
70. Huang EH, Hynes MJ, Zhang T, et al., Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis, Cancer Res, 2009;69:3382-9.
71. Levin TG, Powell AE, Davies PS, et al., Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tract, Gastroenterology, 2010;139:2072-82.e5.
72. Weichert W, Knosel T, Bellach J, et al., ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival, J Clin Pathol, 2004;57:1160-4.
73. von Furstenberg RJ, Gulati AS, Baxi A, et al., Sorting mouse jejunal epithelial cells with CD24 yields a population with characteristics of intestinal stem cells, Am J Physiol Gastrointest Liver Physiol, 2011;300:G409-17.
74. Weichert W, Denkert C, Burkhardt M, et al., Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival, Clin Cancer Res, 2005;11:6574-81.